Dr. Alexander Michael Mantas, MD

Dr. Mantas practices at Digestive Health Center of Dallas in Dallas, Texas.

Dr. Mantas' NPI, 1811193485, was assigned on June 21, 2007. Dr. Mantas holds Texas license N5836.

Dr. Mantas' primary practice is Digestive Health Center of Dallas, at 9500 N Central Expwy Ste 200, Dallas, TX 75231. The practice phone is (214) 739-9544.

Dr. Mantas' primary practice is Digestive Health Center of Dallas in Dallas, Texas. Dr. Mantas is also affiliated with Medical City Dallas Hospital. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Mantas to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mantas practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mantas' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mantas is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Mantas is licensed in Texas.

Dmand AI lists acid reflux, colonoscopy, fatty liver, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Mantas treats.

CMS data shows 329 Medicare services from Dr. Mantas across 6 procedure codes in 2024, for 209 Medicare patients. Medicare paid $35,766 for them.

CMS counts 209 Medicare patients who saw Dr. Mantas in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mantas' median patient age at 52, with 47% women.

In 2024, Dr. Mantas wrote 882 Medicare Part D claims for 186 patients. 91% of them were for generic drugs. CMS names the drug for 747 of them, across 15 drugs with 11 or more claims each, at $178,169 in total drug cost. In 2023, CMS named 734 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mantas for performance year 2024, reported as part of a group. Dr. Mantas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 30 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mantas, more than 55% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Mantas.

CMS Open Payments shows 720 general payments to Dr. Mantas from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $3,959.

Dmand AI lists 1 award for Dr. Mantas, most recently CMS Stage 1 EHR in 2013.

Dr. Mantas is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.